Real World Third COVID19 Vaccine Dosing and Antibody Response in Patients with Hematologic Malignancies [Jul 18, 2022] Mike Thompson, MD, PhD, FASCO , Hallmeyer, Veronica Fitzpatrick , Liao, Michael Mullane, MD Stephen Medlin , Copeland, Jim Weese JPCRR institutionalrepository.aah.org/jpcrr/vol9/iss… #COVID19nCancer #COVID19Vaccine #IDonc

Real World Third COVID19 Vaccine Dosing and Antibody Response in Patients with Hematologic Malignancies [Jul 18, 2022] Mike Thompson, MD, PhD, FASCO , Hallmeyer, Veronica Fitzpatrick , Liao, Michael Mullane, MD Stephen Medlin , Copeland, Jim Weese JPCRR institutionalrepository.aah.org/jpcrr/vol9/iss… #COVID19nCancer #COVID19Vaccine #IDonc

Convalescent Plasma and Survival in Hematologic Malignancy and COVID-19 [Jun 17, 2021] Mike Thompson, MD, PhD, FASCO & Jeff Henderson MDPhD et al. Jack Senefeld Dimpy Shah MD, PhD @hemoncwarner COVID-19 and Cancer Consortium (CCC19) Registry - JAMA Oncology ow.ly/SJJu50FcCmD #COVID19 CP #CCC19 #COVID19 nCancer #COVID19 #IDonc

Crowdsourcing a crisis response for COVID-19 in oncology [Apr 21, 2020] Aakash Desai, MD, MPH @hemoncwarner Nicole Kuderer, MD, MS, FASCO 🌎🇺🇸🇪🇺🇺🇦🌏 Mike Thompson, MD, PhD, FASCO Dear Dr. Researcher, PhD Gary Lyman 🇺🇸🇪🇺🇺🇦💛💙 gilberto lopes Nature Cancer ow.ly/wuyD30qzDyS #CCC19 #COVID19nCANCER COVID-19 and Cancer Consortium (CCC19) Registry

Efficacy of BioNTech SE Pfizer Inc. BNT162b2 mRNA #COVIDVaccine in Pts w/ CLL [6/10/21] Yair Herishanu et al Blood Journal ow.ly/UZSf50F7OJM #NCT04746092 #COVID19 nCancer #CLLsm #leusm #CCC19 #COVID19 COVID-19 and Cancer Consortium (CCC19) Registry Ab response: Remission 79.2%; Tx-naive 55.2%; Active Tx 16.0%

COVID‐19 vaccine effectiveness in patients with hematologic malignancy [May 18, 2022] Dimpy Shah MD, PhD Pankil Mike Thompson, MD, PhD, FASCO Transplant ID onlinelibrary.wiley.com/doi/10.1111/ti… #COVID19Vaccine #COVID19nCancer #bmtsm #leusm #lymsm #mmsm #mpnsm #IDonc

Suboptimal Humoral and Cellular Immune Response to SARS-CoV-2 RNA Vaccination in Myeloma Patients Is Associated with Anti-CD38 and BCMA-Targeted Treatment [Nov 23, 2021] Oliver Van Oekelen Abstract 882 #ASH21 ashpublications.org/blood/article/… #COVID19Vaccine #COVID19nCancer #mmsm cc COVID-19 and Cancer Consortium (CCC19) Registry

Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma [April 19, 2021] Bird et al. The Lancet Haematology ow.ly/ZZsA50FpeyE #mmsm #COVID19Vaccine #COVID19nCancer #CCC19 COVID-19 and Cancer Consortium (CCC19) Registry

COVID-19 and cancer: A review of the registry-based pandemic response [Sep 2, 2021] Aakash Desai, MD, MPH Turab J Mohammed, MD et al. JAMA Oncology ow.ly/8fyz50G38Y4 #COVID19nCancer #CCC19 COVID-19 and Cancer Consortium (CCC19) Registry

Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19: a #CCC19 registry analysis [Mar 9, 2022] Sam Rubinstein et al. Mike Thompson, MD, PhD, FASCO COVID-19 and Cancer Consortium (CCC19) Registry Blood Cancer Discovery ow.ly/wC8F50IgpjR #COVID19 nCancer #COVID19 #bmtsm #leusm #lymsm #mmsm #mpnsm

Association of Clinical Factors & Recent Anti-Cancer Therapy with COVID-19 Severity among Patients with Cancer: A Report from the COVID-19 and Cancer Consortium [3/18/21] Petros Grivas Ali Khaki et al. COVID-19 and Cancer Consortium (CCC19) Registry Annals of Oncology ow.ly/RSt450E2I9U #CCC19 #COVID19nCancer

#Cancer patients have a 2-fold higher risk of dying from #COVID19 than the general US population, data suggest. From JNCI and @thelancetOncol. brnw.ch/21wJptn #COVID19 nCancer

Five Questions With: Sanjay Mishra Sanjay Mishra, PhD [Nov 26, 2023] By Katie Castellani PBN
pbn.com/five-questions… #CCC19 COVID-19 and Cancer Consortium (CCC19) Registry #COVID19nCancer #COVID19Vaccine Donna Rivera Jill Barnholtz-Sloan, Ph.D.

Association of Clinical Factors & Recent Anti-Cancer Therapy with COVID-19 Severity among Patients with Cancer: A Report from the COVID-19 and Cancer Consortium [3/18/21] Petros Grivas Ali Khaki et al. COVID-19 and Cancer Consortium (CCC19) Registry Annals of Oncology ow.ly/RSt450E2I9U #CCC19 #COVID19nCancer

BMT w/in 4 wks of Sars-Cov-2 Infection Is Associated with Increased Risk of Mortality: A National COVID Cohort Collaborative Study [Sat, Dec 10, 2022] Meera Mohan Abst 387 #ASH22 ash.confex.com/ash/2022/webpr… #COVID19 nCancer #bmtsm #IDonc #COVID19 #AMLsm #leusm OR 49.6

Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium ( #CCC19 ) cohort study [Jul 22, 2020] Donna Rivera Solange Peters et al Gary Lyman 🇺🇸🇪🇺🇺🇦💛💙 @hemoncwarner Cancer Discovery ow.ly/e5Fl30qZTno #AACRCovid #COVID19 nCancer n=2186

Covid‐19 and Myeloma: what are the implications for now and in the future? [May 19, 2020] Freeman & Joseph Mikhael Br J Haematol ow.ly/wLDV30qKlDc #mmsm #IDonc #CCC19 #COVID19 nCancer #2019nCoV #COVID19 COVID-19 and Cancer Consortium (CCC19) Registry

The impact of cancer metastases on COVID-19 outcomes: A COVID-19 and Cancer Consortium registry-based retrospective cohort study [Feb 20, 2024] Claire Castellano et al. ACS Journal Cancer
acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… #CCC19 #COVID19 nCancer #COVID19 COVID-19 and Cancer Consortium (CCC19) Registry #camets

Time-Related Biases in Nonrandomized COVID-19–Era Studies Using Real-world Data [Jun 17, 2021] Greg Calip Rebecca Miksad, MD Sarkar JAMA Oncology ow.ly/wTHl50FcSHZ #COVID19 CP #COVID19 nCancer #COVID19 #CCC19 COVID-19 and Cancer Consortium (CCC19) Registry ...real-world data should continue to play a crucial role...

Seroconversion rates following COVID-19 vaccination amongst patients with cancer [Jun 5, 2021] Astha Thakkar et al. Balazs Halmos Cancer Cell ow.ly/59Vf50F9HRR #COVID19Vaccine #COVID19nCancer #CCC19 #leusm #lymsm #mmsm #mpnsm cc COVID-19 and Cancer Consortium (CCC19) Registry HT Julie Gralow